BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25469101)

  • 1. A computed tomography-based spatial normalization for the analysis of [18F] fluorodeoxyglucose positron emission tomography of the brain.
    Cho H; Kim JS; Choi JY; Ryu YH; Lyoo CH
    Korean J Radiol; 2014; 15(6):862-70. PubMed ID: 25469101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
    Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
    PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction.
    Sekine T; Buck A; Delso G; Ter Voert EE; Huellner M; Veit-Haibach P; Warnock G
    J Nucl Med; 2016 Feb; 57(2):215-20. PubMed ID: 26493207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
    Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
    J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial Normalization of
    Lilja J; Leuzy A; Chiotis K; Savitcheva I; Sörensen J; Nordberg A
    J Nucl Med; 2019 Feb; 60(2):285-291. PubMed ID: 29903930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction.
    Sekine T; Ter Voert EE; Warnock G; Buck A; Huellner M; Veit-Haibach P; Delso G
    J Nucl Med; 2016 Dec; 57(12):1927-1932. PubMed ID: 27339875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET.
    Hsiao IT; Huang CC; Hsieh CJ; Wey SP; Kung MP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):908-20. PubMed ID: 23412134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease.
    Bertoglio D; Verhaeghe J; Kosten L; Thomae D; Van der Linden A; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
    PLoS One; 2018; 13(10):e0206613. PubMed ID: 30365550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
    J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis.
    Van Der Gucht A; Verger A; Guedj E; Malandain G; Hossu G; Yagdigul Y; Roch V; Poussier S; Maillard L; Karcher G; Marie PY
    Ann Nucl Med; 2015 Dec; 29(10):921-8. PubMed ID: 26323854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification.
    Presotto L; Iaccarino L; Sala A; Vanoli EG; Muscio C; Nigri A; Bruzzone MG; Tagliavini F; Gianolli L; Perani D; Bettinardi V
    Neuroimage Clin; 2018; 20():153-160. PubMed ID: 30094164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone.
    Andersen FL; Ladefoged CN; Beyer T; Keller SH; Hansen AE; Højgaard L; Kjær A; Law I; Holm S
    Neuroimage; 2014 Jan; 84():206-16. PubMed ID: 23994317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.